+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cell Therapy Market by Cell Type, Therapy Type, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4989916
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cell Therapy Market grew from USD 8.66 billion in 2023 to USD 9.60 billion in 2024. It is expected to continue growing at a CAGR of 10.93%, reaching USD 17.91 billion by 2030.

Cell therapy is a transformative area of medicine involving the administration of live cells for therapeutic purposes, often to repair or replace damaged tissue or fight disease. Its scope broadly encompasses autologous (self-derived), allogeneic (donor-derived), and other innovative cellular forms, including stem cells and genetically engineered cells. The necessity of cell therapy arises from its potential to offer treatments for previously intractable conditions, such as certain cancers, autoimmune diseases, and degenerative disorders. The application of cell therapy spans numerous fields, including oncology, cardiology, orthopedics, and neurology, with end-use principally concentrated in healthcare facilities, research institutions, and biotechnology companies. Key growth factors for the market include advancing biotechnology, increased funding for medical research, and favorable regulatory environments. The advent of personalized medicine further acts as a catalyst, driving demand for bespoke therapeutic solutions. Opportunities abound in the development of off-the-shelf allogeneic therapies and the expansion into emerging markets, which present less-saturated landscapes ripe for penetration. To seize these opportunities, stakeholders should focus on strategic partnerships, investments in scalable manufacturing technologies, and adherence to evolving regulatory standards. However, the market faces challenges such as high treatment costs, stringent regulations, and complex logistics regarding cell sourcing and transportation. Furthermore, ethical concerns around gene editing may influence public perception and support. Innovation can best be targeted at developing more efficient manufacturing methodologies, optimizing cell viability, and improving treatment specificity and safety. The market is characterized by rapid technological advancements and significant investment from private and public sectors, emphasizing dynamic growth yet necessitating robust adaptability. Navigating these complexities requires a proactive approach to regulatory challenges and a keen focus on collaborations that bridge interdisciplinary expertise to sustain momentum and foster breakthroughs in cell therapy’s potential therapeutic benefits.

Understanding Market Dynamics in the Cell Therapy Market

The Cell Therapy Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing Government Investment in Biotech Innovation and Approval Rates in Cell Therapy
    • Improvements in Cell Therapy Supply Chain
  • Market Restraints
    • Side Effects Related to the Stem Cell Transplant
  • Market Opportunities
    • Advancements in Chimeric Antigen Receptor T-cell (CAR-T) Therapies for Cancer Treatments and the Use of ESCs (Embryonic stem cells) and iPSCs (Induced Pluripotent Stem Cells)
    • Increasing Use of Stem Cells for the Treatment of Neurological disorders
  • Market Challenges
    • Ethical Issues Associated with the Use of Stem Cells and Pharmacological Issues

Exploring Porter’s Five Forces for the Cell Therapy Market

Porter’s Five Forces framework further strengthens the insights of the Cell Therapy Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cell Therapy Market

External macro-environmental factors deeply influence the performance of the Cell Therapy Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cell Therapy Market

The Cell Therapy Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cell Therapy Market

The Cell Therapy Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Therapy Market, highlighting leading vendors and their innovative profiles. These include Athersys, Inc., Sartorius AG, BioNTech SE, Anterogen Co., Ltd., Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis AG, Thermo Fisher Scientific, Inc., Stempeutics Research Pvt. Ltd., Vericel Corporation, JCR Pharmaceuticals Co., Ltd., Mesoblast Ltd., Castle Creek Biosciences, Inc., FUJIFILM Holdings Corporation, Gilead Sciences, Inc., Stemedica Cell Technologies, Inc., Medipost Co., Ltd., Smith & Nephew PLC, Bone Therapeutics SA, NuVasive, Inc., Kolon TissueGene, Inc., Lonza Group Ltd., Astellas Pharma Inc., TegoScience, and Bristol-Myers Squibb Company.

Market Segmentation & Coverage

This research report categorizes the Cell Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Cell Type
    • Differentiated Cell
    • Stem Cell
  • Therapy Type
    • Allogenic Therapies
    • Autologous Therapies
  • Application
    • Autoimmune Diseases
    • Dermatology
    • Musculoskeletal Therapies
    • Oncology
  • End-User
    • Biotechnology and Pharmaceutical Companies
    • Hospitals and Clinics
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Government Investment in Biotech Innovation and Approval Rates in Cell Therapy
5.1.1.2. Improvements in Cell Therapy Supply Chain
5.1.2. Restraints
5.1.2.1. Side Effects Related to the Stem Cell Transplant
5.1.3. Opportunities
5.1.3.1. Advancements in Chimeric Antigen Receptor T-cell (CAR-T) Therapies for Cancer Treatments and the Use of ESCs (Embryonic stem cells) and iPSCs (Induced Pluripotent Stem Cells)
5.1.3.2. Increasing Use of Stem Cells for the Treatment of Neurological disorders
5.1.4. Challenges
5.1.4.1. Ethical Issues Associated with the Use of Stem Cells and Pharmacological Issues
5.2. Market Segmentation Analysis
5.2.1. Cell Type: Advancements in stem cells for therapeutic applications
5.2.2. Therapy Type: Increasing adoption of autologous cell therapies for personalized medicines
5.2.3. Application: Advancements in dermatological applications of cell therapies
5.2.4. End-User: Diverse applications of cell therapies in hospitals and clinics for disease management
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
5.5. Client Customization
6. Cell Therapy Market, by Cell Type
6.1. Introduction
6.2. Differentiated Cell
6.3. Stem Cell
7. Cell Therapy Market, by Therapy Type
7.1. Introduction
7.2. Allogenic Therapies
7.3. Autologous Therapies
8. Cell Therapy Market, by Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Dermatology
8.4. Musculoskeletal Therapies
8.5. Oncology
9. Cell Therapy Market, by End-User
9.1. Introduction
9.2. Biotechnology and Pharmaceutical Companies
9.3. Hospitals and Clinics
9.4. Research Institutes
10. Americas Cell Therapy Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Therapy Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cell Therapy Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Pluri Launches New Cell Therapy CDMO Division
13.3.2. Max Healthcare Launches CAR-T Cell Therapy to Improve Cancer Care in Delhi-NCR
13.3.3. Bayer Opens First Cell Therapy Manufacturing Facility to Advance Regenerative Medicines on a Global Scale
List of Figures
FIGURE 1. CELL THERAPY MARKET RESEARCH PROCESS
FIGURE 2. CELL THERAPY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CELL THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CELL THERAPY MARKET DYNAMICS
TABLE 7. GLOBAL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELL THERAPY MARKET SIZE, BY STEM CELL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELL THERAPY MARKET SIZE, BY MUSCULOSKELETAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. CANADA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 36. CANADA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 37. CANADA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. MEXICO CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 41. MEXICO CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. MEXICO CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES CELL THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. CHINA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 58. CHINA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 59. CHINA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CHINA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. INDIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 62. INDIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. INDIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. JAPAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 70. JAPAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 71. JAPAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. JAPAN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. THAILAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 94. THAILAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 95. THAILAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. THAILAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. DENMARK CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 107. DENMARK CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 108. DENMARK CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. DENMARK CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. EGYPT CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 111. EGYPT CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 112. EGYPT CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EGYPT CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. FINLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 115. FINLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 116. FINLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. FINLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. GERMANY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ITALY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 131. ITALY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ITALY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. NORWAY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 143. NORWAY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 144. NORWAY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NORWAY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. POLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 147. POLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 148. POLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. POLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. QATAR CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 151. QATAR CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 152. QATAR CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. QATAR CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SPAIN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. TURKEY CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 180. TURKEY CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. TURKEY CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM CELL THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cell Therapy market, which are profiled in this report, include:
  • Athersys, Inc.
  • Sartorius AG
  • BioNTech SE
  • Anterogen Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Novartis AG
  • Thermo Fisher Scientific, Inc.
  • Stempeutics Research Pvt. Ltd.
  • Vericel Corporation
  • JCR Pharmaceuticals Co., Ltd.
  • Mesoblast Ltd.
  • Castle Creek Biosciences, Inc.
  • FUJIFILM Holdings Corporation
  • Gilead Sciences, Inc.
  • Stemedica Cell Technologies, Inc.
  • Medipost Co., Ltd.
  • Smith & Nephew PLC
  • Bone Therapeutics SA
  • NuVasive, Inc.
  • Kolon TissueGene, Inc.
  • Lonza Group Ltd.
  • Astellas Pharma Inc.
  • TegoScience
  • Bristol-Myers Squibb Company

Methodology

Loading
LOADING...

Table Information